This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SORIN Acquires UCL Spin-off NeuroTECH

"I am very pleased that the unique technological building blocks we have developed for our products, can now be used for the treatment of debilitating diseases otherwise refractory to other treatments, within SORIN GROUP," said Mr. Michel Troosters, founder and past CEO.

"This acquisition represents a further important step forward in our long-term growth initiatives as announced in our recent Strategic Plan," said André- Michel Ballester, Chief Executive Officer of Sorin Group.

Bruno Delvaux, Rector of UCL, added: "Building bridges between science and industry for the benefits of society is one of the key missions of UCL. Our research, through an integrated technology transfer process, contributes directly to address unmet therapeutic needs."

About NeuroTech

Founded in 1994 as a spin-off of Université catholique de Louvain, NeuroTECH's mission ( is to design, develop and bring to market cost-effective active implantable medical devices improving the quality of life of patients suffering from neurological, psychiatric and related disorders. Neurotech's first commercial product, an implantable vagus nerve stimulator, presents two key differentiators: the ADNS-300 uses a rechargeable battery and not only stimulates the vagus nerve but also records neural activity from the left vagus nerve using an innovative cuff electrode. This unique sensing feature enables the physician to capture the "compound action potential" (CAP) generated by the stimulation, which should allow an improved and personalized treatment.

About Sorin Group

Sorin Group (Reuters Code: SORN.MI) is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,750 employees worldwide, Sorin Group focuses on three major therapeutic areas: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over one million patients are treated with Sorin Group devices in more than 80 countries. ( )


2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,826.59 +14.40 0.08%
S&P 500 2,091.71 +2.57 0.12%
NASDAQ 5,122.3180 +19.51 0.38%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs